Novo Nordisk Reports Positive Phase 3 REDEFINE 9 CagriSema Results
Novo Nordisk said the trial evaluating CagriSema, an investigational treatment for adults with overweight or obesity, met its primary results positively.
Novo Nordisk said the trial evaluating CagriSema, an investigational treatment for adults with overweight or obesity, met its primary results positively.